Social Prescribing Intervention for Health Promotion in Community-Dwelling Older Adults (NCT07540117) | Clinical Trial Compass
RecruitingNot Applicable
Social Prescribing Intervention for Health Promotion in Community-Dwelling Older Adults
Taiwan1,500 participantsStarted 2026-04-14
Plain-language summary
This study evaluates the effects of a social prescribing intervention on health promotion outcomes in community-dwelling older adults. The intervention consists of a 4-week mindfulness meditation program followed by a 12-week walking-pole exercise program. The purpose of the study is to determine whether this combined intervention improves physical function, psychological well-being, and sleep quality.
Eligible participants aged 55 years and older will be enrolled from community settings and will receive the same 16-week intervention. Assessments will be conducted at baseline, after the mindfulness phase, after completion of the full intervention, and 3 months after the intervention ends. Study outcomes include physical function, mood, well-being, sleep quality, and indicators of continued participation and lifestyle change.
The investigators hypothesize that the combined social prescribing intervention will lead to improvements in physical and psychological health among community-dwelling older adults and support healthy aging.
Who can participate
Age range
55 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adults aged 55 years and older
* Community-dwelling older adults
* Able to walk independently or with assistive devices
* Normal cognitive function or mild cognitive impairment, with ability to understand and follow study procedures
* Willing to sign informed consent
* Willing to participate in the intervention and complete study assessments
Exclusion Criteria:
* Major surgery or hospitalization within the previous 3 months
* Severe cardiovascular disease or other medical condition making exercise inappropriate, based on physician assessment
* Moderate to severe dementia or other severe psychiatric disorder
* Inability to comply with the 4-week mindfulness meditation program or the 12-week walking-pole exercise program
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Five Times Sit-to-Stand Test
Timeframe: Baseline, at Week 5, and at Week 17
Trial details
NCT IDNCT07540117
SponsorNational Health Research Institutes, Taiwan